OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...

PRNewswire New York [US] 13 Fourth Frontier a medical technology company based out of New York and Bangalore announced the ...

Atrial Fibrillation has been described as a global epidemic ... and cardiac rehabilitation centres to offer at-home remote ...

This makes effective monitoring and early intervention ... After discharge, she was monitored at home for 15 days, during ...

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

The article discusses the evolution and significance of ECG systems in cardiac monitoring. It highlights their role in ...

If you are reading this, we assume you are one of "us" – the 1 in 5 people who have irritable bowel syndrome (IBS). Some of us have diarrhea, some of us have constipation – and some of us get to ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

Adventure Gold [AGLD] recorded a 24-hour trading volume of $1.58 billion, representing a staggering 4105.82% increase in the ...